No Data
Huakang Medical (301235.SZ): "Huayi Convertible Bond" will begin subscription on December 23.
Huakang Medical (301235.SZ) announced that the company intends to issue convertible CSI Enterprise bonds to unspecified objects.
Huakang Medical (301235.SZ): First repurchase of 0.238 million shares involving an investment of 4.9815 million yuan.
On November 26, Gelonhu announced that Huakang Medical (301235.SZ) disclosed its first repurchase on November 25, 2024. The company repurchased for the first time through a repurchase special securities account with a total of 0.238 million shares in a centralized auction trading method, accounting for 0.23% of the total share capital. The lowest transaction price was 20.84 yuan per share, the highest transaction price was 21.00 yuan per share, and the total amount paid was RMB 4.9815 million (excluding transaction costs).
Huakang Medical (301235.SZ): Received a bid notice for a project worth 0.191 billion yuan.
Gelonghui November 25th | Huakang Medical (301235.SZ) announced that recently, the company received the "Winning Bid Notice" issued by the bidding agent Huajie Engineering Consulting Co., Ltd., confirming that the company, together with World Good Environment Technology (Wuhan) Co., Ltd. and China Zhongyuan International Engineering Co., Ltd. formed a consortium (hereinafter referred to as the "consortium") as the winning supplier of the "Tongji Xianning Hospital Construction Project Medical Special Engineering Design Procurement Construction General Contracting" project, with a winning bid price of 190,082,632.30 yuan.
Hua Kang Medical (301235.SZ): won the bid for the special department medical special project of Dongping County Medical Center construction project.
GeLongHui October 31 | HuaKang Medical (301235.SZ) announced that the company recently participated in the tender for the "Dongping County Medical Center Special Department Medical Special Project" project, with Dongping County People's Hospital as the bidding unit. On October 31, 2024, the Tai'an City Public Resource Trading Network published the relevant list of shortlisted candidates. The bidding quote is 59,236,071.66 yuan.
Huakang Healthcare: Report for the third quarter of 2024
Huakang Medical (301235.SZ): The net income for the first three quarters was 19.6354 million yuan, a year-on-year decrease of 67.31%.
On October 29, Gelonghui reported the third quarter of 2024 for Huakang Medical (301235.SZ), with the company achieving revenue of 1.08 billion yuan in the first three quarters, a decrease of 5.72% year-on-year; net income attributable to shareholders of the listed company was 19.6354 million yuan, a decrease of 67.31% year-on-year; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 13.2099 million yuan, a decrease of 75.38% year-on-year; and basic earnings per share were 0.19 yuan.
See the daily top gainer.
